ALSO READGST impact: GSK Pharma's June quarter profit down 64% on de-stocking GSK to invest Rs 1,000 cr in Karnataka for new plant Indian destocking hits GSK consumer health care business Thane land deal raises Oberoi Realty's prospects GlaxoSmithKline sets up first team for acquisitions in 93 years
Drug firm GlaxoSmithKline Pharmaceuticals on Wednesday reported a 31.83 per cent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017.
The company had posted a net profit of Rs 98.85 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.
Standalone total income of the company also rose to Rs 845.87 crore for the quarter under consideration as against Rs 817.20 crore in the same period a year ago.
Shares of GlaxoSmithKline Pharmaceuticals today closed at at Rs 2,422.80 per scrip on BSE, down 0.99 per cent from its previous close.